51. Matrix metalloproteinase 2: an important genetic marker for cholesteatomas.
- Author
-
Morales DS, Penido Nde O, da Silva ID, Stávale JN, Guilherme A, and Fukuda Y
- Subjects
- Adolescent, Adult, Aged, Biomarkers metabolism, Cholesteatoma, Middle Ear metabolism, Cohort Studies, Cross-Sectional Studies, Female, Humans, Immunohistochemistry, Male, Middle Aged, Neoplasm Invasiveness, Cholesteatoma, Middle Ear enzymology, Matrix Metalloproteinase 2 metabolism
- Abstract
Aim: This study is to determine the MMP2s presence in cholesteatomas and whether complicating cholesteatomas show a higher immunohistochemical expression of matrix metalloproteinase 2. Cholesteatoma produces enzymes that cause bone erosion like matrix metalloproteinase 2 (MMP2)., Material and Methods: We analyzed the expression of MMP2 in invasive (causing complications) compared to latent cholesteatomas (not causing complications). A cross-sectional study with nineteen slides and paraffin blocks of cholesteatomas derived from mastoidectomies were located and processed, including 8 invasive and 11 latent cholesteatomas. Immunohistochemical technique was empregated to MMP2., Results: The results are expressed as 0, + (to low), ++ and +++(high) according to the quantity and color of the immunohistochemical staining of MMP2. Higher expression of MMP2 was observed in 7 (87.5%) of the 8 invasive cholesteatomas. With respect to latent cholesteatomas, higher expression of MMP2 was observed in 27.3% (3 cases), with Fishers exact test indicating a significant difference (p=0.015)., Conclusions: Cholesteatoamas express MMP2 and Invasive cholesteatomas had high MMP2 compared to latent cholesteatomas.
- Published
- 2007
- Full Text
- View/download PDF